[Retracted] Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity

Table 1

Basic clinical information and abnormal laboratory results of the four patients in this report.

Patient number	Age/gender	Stage	Pathology	Location of lesions	Abnormal laboratory results
					Index	Value	Reference range
H81	66 y/male	II	SCC	Left upper lobe	Monocyte percentage	0.09%	3.0%–8.0%
					Eosinophilic granulocyte percentage	0.05%	1.0%–5.0%
					Basophilic granulocyte count	0.42 × 10^9	0.05–0.30 × 10^9
					INR	1.19 R	0.80–1.10 R
					TBA	18.5 μmol/L	0–10 μmol/L
					Homocysteine	18.1 μmol/L	3–15 μmol/L
					Blood glucose	3.9 mmol/L	4.1–5.9 mmol/L
he_78	66 y/female	I	ADC	Left upper lobe	Blood glucose	8.1 mmol/L	4.1–5.9 mmol/L
					Amylase	119 U/L	<100 U/L
he_57	63 y/male	IV	SCLC	Right lower lobe	Eosinophilic granulocyte percentage	0.80%	1.0%–5.0%
					Potassium	3.44 mmol/L	3.5–5.1 mmol/L
					Calcium	2.16 mmol/L	2.18–2.60 mmol/L
					Myoglobin	21.00 ng/ml	28–72 ng/ml
he_80	80 y/male	III	ADC	Left lower lobe	Hemoglobin	99.0 g/l	130–175 g/l
					Red cell count	3.48 × 10^12/L	4.3–5.8 × 10^12/L
					Neutrophil percentage	0.43%	50.0–70.0%
					Lymphocyte percentage	0.44%	20.0–40.0%
					Monocyte percentage	0.10%	3.0–8.0%
					D-Dimer	268 ng/ml	0–232 ng/ml
					Blood glucose	7.0 mmol/L	4.1–5.9 mmol/L
					Oxygen partial pressure	70.3 mmHg	80–100 mmHg
					Total hemoglobin	10.8 g/dL	12–17.5 g/dL
					Oxygen saturation	0.948	96–100%
					Oxyhemoglobin	0.925	94–99%
					Methemoglobin	0.009	0.2–0.6%
					Standard alkali remaining	3.4 mmol/L	−3–3 mmol/L
					Alkali remaining	3.3 mmol/L	−3–3 mmol/L
					Bicarbonate	27.4 mmol/L	22–27 mmol/L
					Standard bicarbonate	27.3 mmol/L	22–27 mmol/L
					Alveolar-arterial partial pressure difference	31.5 mmHg	8–25 mmHg

SCC, small cell lung cancer; ADC, adenocarcinoma; SCLC, small cell lung cancer; INR, international normalized ratio; TBA, total bile acids.